Juranes, Mary Kris C.
HRN: 22-24-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
CEFUROXIME 500MG (TAB)
12/15/2022
12/21/2022
ORAL
500mg
BID
SP RMLE, PROM X 4 HRS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes